ACH
Accendra Health Inc.

3,247
Mkt Cap
$217.5M
Volume
671,027.00
52W High
$9.55
52W Low
$1.84
PE Ratio
-0.20
ACH Fundamentals
Price
$2.84
Prev Close
$2.89
Open
$2.86
50D MA
$2.96
Beta
1.16
Avg. Volume
719,768.80
EPS (Annual)
-$14.31
P/B
-0.47
Rev/Employee
$424,928.00
$2,096.79
Loading...
Loading...
News
all
press releases
Are Options Traders Betting on a Big Move in Accendra Health Stock?
Investors need to pay close attention to ACH stock based on the movements in the options market lately.
Zacks
News Placeholder
More News
News Placeholder
Accendra Health Announces Offers and Consent Solicitations
Accendra Health, Inc. (NYSE: ACH) (the Company) today announced that it has commenced an offer to exchange (the Exchange Offers) any and all of the Companys outstanding 4.500% Senior Notes due 2029 (the 2029 Notes) and 6.625% Senior Notes due 2030 (the 2030 Notes and, together with the 2029 Notes...
Business Wire
News Placeholder
Accendra Health (ACH) Q1 2026 Earnings Transcript
Accendra Health (ACH) Q1 2026 Earnings Transcript...
Yahoo! Finance: News
News Placeholder
Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction
Accendra Health, Inc. (NYSE: ACH) today reported financial results for the first quarter ended March 31, 2026, and announced a more than $1.5 billion comprehensive balance sheet optimization...
Business Wire
News Placeholder
WAT Q1 Earnings Beat Estimates, BD Acquisition Aids Revenues
Waters crushes Q1 2026 estimates as revenues surge 91.5%; newly acquired BD units top targets early, and 2026 guidance moves higher.
Zacks
News Placeholder
Accendra Health Announces First Quarter 2026 Earnings Release Date and Conference Call
Accendra Health, Inc. (NYSE: ACH) (the Company) plans to release financial results for the first quarter of 2026 on Monday, May 11, 2026, before trading begins on the New York Stock Exchange. The...
Business Wire
News Placeholder
Accendra Health (NYSE:ACH) Stock Rating Upgraded by Zacks Research
Zacks Research raised shares of Accendra Health from a "strong sell" rating to a "hold" rating in a report on Tuesday...
MarketBeat
News Placeholder
Is the Options Market Predicting a Spike in Accendra Health Stock?
Investors need to pay close attention to Accendra Health stock based on the movements in the options market lately.
Zacks
News Placeholder
Accendra Health Reports Fourth Quarter 2025 Financial Results
Accendra Health, Inc. (NYSE: ACH) today reported financial results for the fourth quarter ended December 31, 2025. Unless otherwise noted, the results herein reflect the Companys continuing...
Business Wire
News Placeholder
Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call
Accendra Health, Inc. (NYSE: ACH) (the Company) plans to release financial results for the fourth quarter of 2025 on Thursday, February 19, 2026, after trading ends on the New York Stock Exchange...
Business Wire
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available